<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04101396</url>
  </required_header>
  <id_info>
    <org_study_id>FF-2019-351</org_study_id>
    <nct_id>NCT04101396</nct_id>
  </id_info>
  <brief_title>4 vs 7 Points Blood Glucose Monitoring in Gestational Diabetes on Dietary Modification</brief_title>
  <official_title>4 Versus 7 Points Self-monitoring Blood Glucose in Gestational Diabetes on Diet Modification-A Randomised Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University of Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University of Malaysia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare between 4 and 7 points blood glucose monitoring in women with
      gestational diabetes on diet modification.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All women with gestational diabetes on diet modification will be recruited and randomised to
      4 versus 7 points self monitoring blood glucose. They will be followed up 4 weekly and the
      pregnancy outcomes will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 25, 2019</start_date>
  <completion_date type="Anticipated">January 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All women with gestational diabetes are randomised to 4 or 7 points of self monitoring blood glucose.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>From date of randomisation up to 40 weeks gestation</time_frame>
    <description>Mean gestational age at delivery in weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>From date of randomisation up to 40 weeks gestation and participants are diagnosed in established labour</time_frame>
    <description>Rate of spontaneous or induced labour in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>From date of randomisation up to 40 weeks gestation when the participants had given birth to the newborn</time_frame>
    <description>Rate of vaginal, instrumental or caesarean delivery in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>From date of randomisation up to 40 weeks gestation during progress of labour up to 24 hours post delivery</time_frame>
    <description>Rate of intrapartum complications such as postpartum haemorrhage, shoulder dystocia and third or fourth degree tear in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>At the point of birth of the neonate</time_frame>
    <description>Mean neonatal birth weight in kilogram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>At the point of birth of the neonate</time_frame>
    <description>Rate of neonates born with Apgar score at five minutes of less than 7 in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>At the point of birth of the neonate</time_frame>
    <description>Rate of neonatal intensive care unit admission in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy outcome of participants</measure>
    <time_frame>From date of randomisation up to 7 days after birth of the neonate</time_frame>
    <description>Rate of neonatal complications such as intrauterine fetal demise, neonatal death, neonatal hypoglycaemia, neonatal jaundice, neonatal respiratory distress syndrome and neonatal sepsis in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation</time_frame>
    <description>Mean age of participants in years</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation</time_frame>
    <description>Rate of each different races such as Malay, Chinese and Indian in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation</time_frame>
    <description>Rate of parity such as nulliparous or multiparous in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation based on the first trimester weight documented in the antenatal record</time_frame>
    <description>Mean prepregnancy body mass index in kg/m^2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation till 40 weeks gestation</time_frame>
    <description>Mean total weight gain in kilogram</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Rate of positive family history of diabetes mellitus in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Rate of previous pregnancy affected by gestational diabetes mellitus in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Demographic data of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Rate of previous pregnancy complicated by fetal macrosomia in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Mean gestational age gestational diabetes mellitus is diagnosed in weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Mean fasting glucose level from the modified glucose tolerance test in mmol/l</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>On the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Mean two hours post 75 gram glucose load from the modified glucose tolerance test in mmol/l</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>At the point of randomisation till 40 weeks gestation</time_frame>
    <description>Rate of antenatal complications such as preeclampsia, threatened preterm labour, preterm prelabour rupture of membranes, anaemia,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>At the point of randomisation till 40 weeks gestation</time_frame>
    <description>Mean level of glycosylated haemoglobin in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>At the point of randomisation till 40 weeks gestation</time_frame>
    <description>Mean level of serum fructosamine in percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>At the point of randomisation till 40 weeks gestation</time_frame>
    <description>Mean level of fasting blood glucose in self monitoring blood glucose in mmol/l</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>At the point of randomisation till 40 weeks gestation</time_frame>
    <description>Mean level of pre-meal blood glucose in self monitoring blood glucose in mmol/l</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical characteristics of participants</measure>
    <time_frame>At the point of randomisation till 40 weeks gestation</time_frame>
    <description>Mean level of one hour post-meal blood glucose in self monitoring blood glucose in mmol/l</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Requirement of treatment in participants</measure>
    <time_frame>From the date of randomisation up to 40 weeks gestation</time_frame>
    <description>Mean gestational age that the participants are detected to require added treatment in weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirement of treatment in participants</measure>
    <time_frame>From point of randomisation till 40 weeks gestation</time_frame>
    <description>Rate of type of treatment needed such as oral hypoglycaemic agent only, combination of insulin and oral hypoglycaemic agent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants' compliance</measure>
    <time_frame>From point of randomisation till 40 weeks gestation</time_frame>
    <description>Rate of frequency of four weekly self blood glucose monitoring in percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participants' satisfaction</measure>
    <time_frame>From point of randomisation till 40 weeks gestation</time_frame>
    <description>Rate of participants' satisfaction whether satisfied, neutral or not satisfied in percentage</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Gestational Diabetes Mellitus in Pregnancy</condition>
  <arm_group>
    <arm_group_label>4 points blood glucose monitoring</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>4 points of self monitoring blood glucose which comprises of fasting, 1 hour post breakfast, 1 hour post lunch and 1 hour post dinner</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7 points blood glucose monitoring</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>7 points of self monitoring blood glucose which comprises of fasting,1 hour post breakfast, 1 hour pre and post lunch, 1 hour pre and post dinner, pre bed at 10 pm</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>diabetic diet</intervention_name>
    <description>Patients with gestational diabetes will be seen by the dietitian to be taught diet modification</description>
    <arm_group_label>4 points blood glucose monitoring</arm_group_label>
    <arm_group_label>7 points blood glucose monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 18-45 years old

          -  Pregnant women with gestational diabetes mellitus on diet modification

          -  Confirmed gestational diabetes mellitus using National Institute for Health and Care
             Excellence guideline by 75g oral glucose tolerance test after 14 weeks

          -  Gestational age at recruitment 20-34 week

        Exclusion Criteria:

          -  bad obstetrics history.

          -  Women with underlying medical disorders such as hypertension, autoimmune diseases on
             steroids

          -  fetal anomaly.

          -  Women planning to deliver in other centres

          -  Women who refuse to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noor Dalila Berohan</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University of Malaysia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Norasyikin Abd Wahab</last_name>
    <role>Study Director</role>
    <affiliation>National University of Malaysia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shuhaila Ahmad</last_name>
    <role>Study Chair</role>
    <affiliation>National University of Malaysia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rahana Abd Rahman</last_name>
    <phone>+60122719985</phone>
    <email>drrahana@ppukm.ukm.edu.my</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nor Azlin Mohamed Ismail</last_name>
    <phone>+60193122255</phone>
    <email>azlinm@ppukm.ukm.edu.my</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Antenatal clinic, UKM Medical Centre</name>
      <address>
        <city>Cheras</city>
        <state>Kuala Lumpur</state>
        <zip>56000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rahana Abd Rahman</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National University of Malaysia</name>
      <address>
        <city>Cheras</city>
        <state>Kuala Lumpur</state>
        <zip>56000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rahana Abd Rahman</last_name>
      <phone>+60122719985</phone>
      <email>drrahana@ppukm.ukm.edu.my</email>
    </contact>
    <contact_backup>
      <last_name>Nor Azlin Mohamed Ismail</last_name>
      <phone>+60193122255</phone>
      <email>azlinm@ppukm.ukm.edu.my</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>September 17, 2019</study_first_submitted>
  <study_first_submitted_qc>September 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2019</study_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National University of Malaysia</investigator_affiliation>
    <investigator_full_name>Rahana Abd Rahman</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>diet modification, 4 and 7 points monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Pregnancy in Diabetics</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The IPD will only be shared upon request. The data that can be shared will be the blood glucose levels and pregnancy outcomes.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

